Moberg Pharma AB (publ)
OTC:MBGPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moberg Pharma AB (publ)
OTC:MBGPF
|
SE |
|
E
|
Equitable Holdings Inc
SWB:AXJ
|
US |
|
M
|
Minebea Mitsumi Inc
F:MEA
|
JP |
|
Penguin Solutions Inc
NASDAQ:PENG
|
US |
|
F
|
Fidelity National Financial Inc
F:F1EF
|
US |
|
F
|
Fuyo General Lease Co Ltd
TSE:8424
|
JP |
|
S
|
Standard Bank Group Ltd
JSE:SBK
|
ZA |
|
T
|
Temapol Polimer Plastik ve Insaat Sanayi Ticaret AS
IST:TMPOL.E
|
TR |
|
T
|
Traton SE
F:8TRA
|
DE |
|
J
|
JD.com Inc
NASDAQ:JD
|
CN |
|
Dexcom Inc
XETRA:DC4
|
US |
|
STERIS plc
F:2TG
|
IE |
|
Implenia AG
SIX:IMPN
|
CH |
|
Halliburton Co
NYSE:HAL
|
US |
|
Topps Tiles PLC
F:929
|
UK |
|
Datametrex AI Ltd
F:D4G
|
CA |
|
Rosseti Sibir' PAO
MOEX:MRKS
|
RU |
|
BE Semiconductor Industries NV
F:BSI
|
NL |
|
B
|
Balchem Corp
SWB:BL9B
|
US |
Bankruptcy Probability
Moberg Pharma AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Moberg Pharma AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Moberg Pharma AB (publ)
STO:MOB
|
516.2m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
202.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
257.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Moberg Pharma AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Moberg Pharma AB (publ) has no debt.
You can find a full breakdown on its Balance Sheet.